Vesper Bio ApS

CVRCVR number32879861

Core data

Name	Vesper Bio ApS
Address	Hauser Plads 10 4, 1127, København K
Founded	Apr 19, 2010
	8 / 7
Locations (P-units)	1 View locations
Website	https://www.vesperbio.com/
Branch	Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Name	Vesper Bio ApS
Address	Hauser Plads 10 4, 1127, København K
Founded	Apr 19, 2010
	8 / 7

Locations (P-units)	1 View locations
Website	https://www.vesperbio.com/
Branch	Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)

Keep track of Vesper Bio ApS

Get an email when we detect changes to financial reports, ownership or management. Save yourself checking the company again.

Free account

Description

Vesper Bio is developing selective Sortilin inhibitors using oral small molecules for neurological diseases with high unmet need.

Vesper Bio targets Sortilin with oral small molecules that selectively modulate ligand binding and interrupt key protein-protein interactions, with potential applications in neuroinflammation, apoptosis reduction, and improved lysosomal function.

Company's own description on virk.dk

Primary activities Selskabets aktiviteter består i at drive forskningsvirksomhed rettet mod udvikling af lægemidler til behandling af diabetes, diabetesrelaterede matboliske sygdomme, fedme og fedmerelaterede sygdomme, og/eller at udføre aktiviteter, der er forbundet hermed. The company's activities comprise to research and development of new medicines directed against treatment of deabetes, diabetes related diseases, obesity and obesity related diseases and/or activities related her to.

Products & services

Selective Sortilin inhibitors · Orally available small molecules · Reversible inhibition of Sortilin

Industries

Healthcare

Financials

View detailed financials

Company financials

Reporting period	2025DKK	2024Locked	2023Locked	2022Locked	2021Locked	2020Locked	2019Locked	2018Locked
Gross profit	-36,446,130	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Operating profit	-42,490,584	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Profit before tax	-62,785,874	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Net income	-48,200,991	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Total assets	65,945,947	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Equity	-227,433,239	Locked	Locked	Locked	Locked	Locked	Locked	Locked
Avg. employees	8	Locked	Locked	Locked	Locked	Locked	Locked	Locked
2018–2025 Unlock financial history

Datapublica Risk Score

Locked

Assesses the risk of financial distress using the company’s accounts, history, and connections.

Company score

0 · Low100 · High

What goes into the assessment

Financials
Equity ratio, profitability, and liquidity
Accounts and history
Late filings and previous financial distress
Owners and management
Past bankruptcies and owners’ other companies
Company and connections
Age, industry, and shared addresses or contact details

Standard: Score and risk bandPro: Also a detailed explanation of the factors

See plans Learn about Risk Score

Contact

From cvr.dk

Contact	Phone	Email
Company	2362****Show full	j**@vesperbio.comShow full

From vesperbio.com

Contact	Phone	Email
Main	—	in**@vesperbio.comShow full

Gazelle

Loading gazelle status…

Børsen Gazelle is Dagbladet Børsen's award. Datapublica is not affiliated with Børsen. Calculated statuses are Datapublica's own analysis of public CVR financial-statement data.

People

Person	Roles	Titles
Jacob Falck Hansen	Roles Management	TitlesADM. DIR.

Auditor

Audit firm	Auditor	Role	From
Beierholm	AuditorPhilip Heick-Poulsen	RoleStatsaut. revisor	FromMar 12, 2026

Legal owners

View ownership diagram

Owner	Ownership	Voting rights	From
LUNDBECKFONDEN	Ownership66.67–89.99 %	Voting rights66.67 %	FromSep 25, 2015
75PMK Holding ApS	Ownership20–24.99 %	Voting rights20 %	FromDec 15, 2017

Ultimate owners